Alterity Therapeutics Limited Share Price OTC Markets
Stocks
PRNA.F
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
11:00:29 26/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.4000 USD | +14.29% |
|
+14.29% | +28.00% |
| Market Cap | 8.11Cr 6.99Cr 6.56Cr 5.98Cr 11Cr 775.57Cr 11Cr 78Cr 30Cr 391.5Cr 30Cr 30Cr 1.3TCr | P/E 2027 * |
-0.4x | P/E 2028 * | -0.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4.02Cr 3.47Cr 3.25Cr 2.97Cr 5.59Cr 384.65Cr 5.61Cr 39Cr 15Cr 194.17Cr 15Cr 15Cr 643.83Cr | EV / Sales 2027 * |
19.3x | EV / Sales 2028 * | 13.7x |
| Free-Float |
92.18% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Alterity Therapeutics Limited
| 1 day | +14.29% | ||
| 1 week | +14.29% | ||
| Current month | +14.29% | ||
| 1 month | +14.29% | ||
| 3 months | +627.27% | ||
| 6 months | -20.79% | ||
| Current year | +28.00% |
| 1 week | 0.4 |  | 0.4 |
| 1 month | 0.4 | | 0.4 |
| Current year | 0.01 | | 0.55 |
| 1 year | 0.01 | | 0.55 |
| 3 years | 0.01 | | 0.7 |
| 5 years | 0.01 | | 2.36 |
| 10 years | 0 | | 3.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
Abby Macnish
DFI | Director of Finance/CFO | - | 30/09/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +14.29% | +14.29% | - | - | 8.11Cr | |
| -0.78% | -1.42% | +2.96% | +20.82% | 5.05TCr | |
| -6.00% | -0.75% | +447.48% | +524.26% | 4.46TCr | |
| -0.24% | +0.74% | +37.18% | +16.57% | 4.31TCr | |
| -1.55% | -2.07% | +19.83% | +73.63% | 4.17TCr | |
| -0.31% | -0.83% | +19.47% | +48.24% | 3.32TCr | |
| -1.79% | -3.24% | +26.32% | +121.63% | 1.68TCr | |
| -0.58% | -2.12% | - | - | 1.63TCr | |
| -0.88% | -0.66% | +11.63% | +28.71% | 1.46TCr | |
| -1.66% | -1.25% | +78.49% | +39.02% | 1.39TCr | |
| Average | +0.05% | -1.39% | +80.42% | +109.11% | 3.05TCr | |
| Weighted average by Cap. | -1.70% | -1.21% | +96.28% | +126.98% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 20.9L 18.01L 16.89L 15.42L 29.04L 20Cr 29.14L 2Cr 78.18L 10Cr 78.48L 76.77L 33Cr | 32.1L 27.66L 25.93L 23.67L 44.59L 31Cr 44.73L 3.08Cr 1.2Cr 15Cr 1.21Cr 1.18Cr 51Cr |
| Net income | -3Cr -2.58Cr -2.42Cr -2.21Cr -4.17Cr -286.61Cr -4.18Cr -29Cr -11Cr -144.68Cr -11Cr -11Cr -479.74Cr | -3.36Cr -2.9Cr -2.71Cr -2.48Cr -4.67Cr -321.14Cr -4.68Cr -32Cr -13Cr -162.11Cr -13Cr -12Cr -537.53Cr |
| Net Debt | -4.09Cr -3.52Cr -3.3Cr -3.02Cr -5.68Cr -390.92Cr -5.7Cr -39Cr -15Cr -197.33Cr -15Cr -15Cr -654.32Cr | -3.72Cr -3.2Cr -3Cr -2.74Cr -5.16Cr -355.08Cr -5.18Cr -36Cr -14Cr -179.24Cr -14Cr -14Cr -594.33Cr |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
- PRNA.F Stock
Select your edition
All financial news and data tailored to specific country editions
